arrow
J

Juan Gómez Rivas

Hospital Clínico San Carlos
H指数:38
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world Data to Assess the Applicability of Randomized Controlled Trials in Newly Metastatic Prostate Cancer

真实世界数据评估随机对照试验在新发转移性前列腺癌中的适用性

2026-10-230
PRE
Whole-pelvic Versus Prostate-only Radiotherapy in Clinically Node-negative High-Risk Localised Prostate Cancer: A Systematic Review and Meta-analysis with Reconstructed Individual-patient Data

临床N0期局部高危前列腺癌全盆腔与前列腺单放治疗的系统评价与基于重建个体患者数据的Meta分析

2026-09-010
PRE
ADVANCING LAPAROSCOPIC TRAINING IN UROLOGY: ESTABLISHING THE LUSS3 CADAVERIC MODEL WITHIN THE EUROPEAN SCHOOL OF UROLOGY CURRICULUM

推进泌尿外科腹腔镜培训:在欧洲泌尿外科学院课程中建立LUSS3尸体模型

2026-05-010
PRE
Consensus-informed Development of Scoring Systems for Intermediate Laparoscopic Simulation Modules: An ESU Laparoscopic Workgroup Initiative

共识指导下的腹腔镜模拟中级模块评分系统开发:ESU 腹腔镜工作组倡议

2026-04-150
OAAI
The role of focal therapy for localized prostate cancer: From diagnosis to ablation

罗尔丹-特斯蒂亚诺, R.; 罗德里格斯-桑切斯, L.; 罗德里格斯·索卡尔拉斯, M.E.; 德·安德烈斯·博维勒, G.; 杜拉索-鲁伊斯, F.; 戈麦斯·里瓦斯, J.; 阿尔法姆布拉·费尔南德斯, H.; 桑切斯·马西亚斯, J.; 比安科, F.J.; 米尼扬纳·洛佩斯, B.; 等. 局限性前列腺癌的局部治疗作用:从诊断到消融. Actas Urol. Esp. 2026, 50, 501918. [Google Scholar] [CrossRef]

2026-03-011
PRE
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography

Gandaglia, G.; Barletta, F.; Scuderi, S.; Scilipoti, P.; Rajwa, P.; Huebner, N.A.; Gomez Rivas, J.; Ibanez, L.; Soeterik, T.F.W.; Bianchi, L.; 等. 前列腺癌患者中筛选盆腔淋巴结清扫候选者的列线图的体外验证(针对术前前列腺特异性膜抗原正电子发射断层扫描结果为阴性的患者). Eur. Urol. Oncol. 2025; in press. [Google Scholar] [CrossRef] [PubMed]

2026-02-0112
PRE
Real-world Evidence on Baseline Characteristics and Treatment in Metastatic Hormone-sensitive Prostate Cancer: Findings from the PIONEER 2.0 Big Data Investigation Group

真实世界证据:转移性激素敏感性前列腺癌的基线特征和治疗——PIONEER 2.0大数据调查组的研究发现

2025-10-070
OAAI
Observational Health Data Analysis of the Cardiovascular Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform

基于PIONEER平台的大数据分析:转移性激素敏感性前列腺癌患者系统性治疗心血管不良事件的真实世界数据研究

2025-10-030
PRE
Beyond PSA: The Future of Prostate Cancer Diagnosis Using Artificial Intelligence, Novel Biomarkers, and Advanced Imagery

超越PSA:人工智能、新型生物标志物和先进影像学在前列腺癌诊断中的未来

2025-09-290
OAAI
Prostate-Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone-Sensitive Prostate Cancer Treated With Apalutamide

接受阿帕卢他胺治疗的转移性激素敏感性前列腺癌中,六个月时的前列腺特异性抗原反应可预测疾病进展。

2025-09-040
PRE
Oncological Outcomes After Robotic Salvage Radical Prostatectomy in Patients Primarily Treated With Focal Versus Radiation Therapy: A Junior ERUS/YAU Collaborative Study

机器人挽救性根治性前列腺切除术后的肿瘤学结局:比较接受局部治疗与放疗作为初始治疗患者的初步ERUS/YAU合作研究

2025-07-230
OA
Implementing Standardised Training and Education: The Vision of the European Association of Urology Led by the European School of Urology

实施标准化培训和教育:由欧洲泌尿外科学院引领的欧洲泌尿外科学会愿景

2025-07-160
OA
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer − a systematic review and expert consensus

数字病理学生物标志物在指导基于放射治疗的 prostate cancer 治疗概念中的应用 − 一项系统综述和专家共识

2025-07-090
PRE
Assessment of the Reporting and Incidence of Prostate Cancer Unconventional Histologies in Tertiary Referral Institutions: An Under-reported but Exploding Phenomenon?

对三级转诊机构中前列腺癌非常规组织学类型的报告与发病率评估:一个未被充分报道但急剧增长的现象?

2025-06-010
OAAI
Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life—A Systematic Review and Meta-analysis

雄激素受体通路抑制剂单药治疗在前列腺癌中的应用:安全性、肿瘤学结局及生活质量——一项系统评价和Meta分析

2025-05-010
OAAI